LD50 (Median Lethal Dose)

How LD50 is determined

LD50 values are derived from dose–response experiments or models that estimate the dose producing a 50% mortality rate in the study group. Experimental determination traditionally involved graded dosing of a test population and recording deaths over a set period. Modern estimates often use statistical methods such as probit or logistic regression applied to observed survival data. LD50 depends on several factors: the species tested, the route of exposure (oral, dermal, inhalation), the formulation and purity of the substance, and the observation interval after dosing.

History, regulatory use and controversy

The concept of a median lethal dose was introduced in the early 20th century and became a standard metric in toxicology and regulatory classification of chemicals and pesticides. Over time it has been the basis for acute-toxicity labelling and hazard categories. However, LD50 testing on animals attracted ethical criticism and scientific concern about interspecies relevance and variability. Beginning in recent decades, regulatory bodies and scientific organizations have promoted alternatives and reduced reliance on traditional animal LD50 tests.

Uses, limitations and related measures

• Uses: LD50 is used as a comparative indicator of acute toxicity and to inform hazard classification, emergency response, and risk communication.
• Limitations: It provides no information about sublethal effects, chronic toxicity, carcinogenicity, reproductive harm, or dose–time relationships. Results vary by species and experimental conditions and cannot be directly translated to human risk without additional data.
• Related measures: LC50 (median lethal concentration) applies to airborne or aquatic exposures; ED50 denotes an effective dose for a specified nonlethal effect; the therapeutic index and margin of safety compare toxic and effective doses.

Alternatives and modern trends

Because of ethical and scientific concerns, many laboratories and regulators now favor non-animal approaches where feasible. These include in vitro cell and tissue assays, computational models such as quantitative structure–activity relationships (QSARs), and integrated testing strategies that combine multiple data sources. Regulatory agencies have begun to accept validated alternative methods for certain endpoints, reducing the need for classical LD50 animal tests.

In practice, LD50 remains a historical and sometimes still-used descriptor of acute hazard, but it is one of many metrics experts consult when assessing chemical safety. Interpreting any LD50 value requires attention to the context of the test conditions, species differences, and complementary toxicological information.